Annual Drug Patent Expirations for INVEGA+TRINZA
Invega Trinza is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
INVEGA TRINZA drug price trends.
Drug patent litigation for INVEGA TRINZA.
This drug has twenty-six patent family members in twenty-four countries.
The generic ingredient in INVEGA TRINZA is paliperidone palmitate. One supplier is listed for this compound. Additional details are available on the paliperidone palmitate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com